FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for...

Maharashtra FDA Withdraws Drug License Cancellation Order for Cipla C&F Unit Following Bombay High Court Rebuke

In a major regulatory development, the Maharashtra Food and Drug Administration (FDA) has withdrawn its order cancelingthe drug sale...

FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for the treatment of polycythemia vera. Polycythemiavera is a rare, chronic blood cancer that affects approximately...

Maharashtra FDA Withdraws Drug License Cancellation Order for Cipla C&F Unit Following Bombay High Court Rebuke

In a major regulatory development, the Maharashtra Food and Drug Administration (FDA) has withdrawn its order cancelingthe drug sale license of Cipla Pharma & Life Sciences Ltd’sCarrying and Forwarding (C&F) unit in Wadki, Pune....

Amylyx Pharmaceuticals Announces Positive Phase 3 Trial Results for Avexitide, for Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals has announced positive top-line results from its pivotal Phase 3 LUCIDITY trial evaluating avexitide, a first-in-class...

Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial

Pharmaceutical giants Merck and Modernarevealed encouraging results from their Phase 3 INTerpath-001 study, testing an individualized mRNA cancer vaccine...

Glenmark Secures U.S. FDA Approval for Flonase®️ Nasal Spray

Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New...

Chai Discovery Collaborates with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery

Chai Discovery has announced a strategic collaboration with Bristol Myers Squibb (BMS) to accelerate AI-powered antibody discovery, moving...

Massive ₹5 Crore Fake Medicine Scam Uncovered Near Bengaluru

The Drug Enforcement Wing of Karnataka’s Food Safety and...

Avalon Pharma and Bio-Thera Execute Exclusive Commercialization Agreement for BAT2406 in MENA

Avalon Pharma and Bio-Thera Solutions, Ltd. announced an exclusive...

DONT MISS

Trending NOW

Most Popular

FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results

Takeda announced that the U.S. Food and Drug Administration...

​OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets

OneSource Speciality Pharma has entered into a strategic manufacturing...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand,...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International...

Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery

Momentis Surgical has secured 510(k) clearance from the U.S. Food...

General News

Maharashtra FDA Withdraws Drug License Cancellation Order for Cipla C&F Unit Following Bombay High Court Rebuke

In a major regulatory development, the Maharashtra Food and...

Orsini Partners with Priovant to Support Access to New Dermatomyositis Therapy LISRAYA

Orsini, a specialty pharmacy known for its work in...

‘Shwas Kavach’ Initiative Gains Government Recognition for AI-Enabled Last-Mile Medical Oxygen Network

Shwas Kavach, an initiative aimed at strengthening India's last-mile medical...

India’s First AYUSH University to Build 100-Acre Permanent Campus in Kurukshetra, Haryana

The Ministry of Ayush announced the development of the permanent campus...

Become a member

Dose Daily News is your trusted source for the latest updates in healthcare and pharmaceuticals. We deliver clear, reliable, and timely news to keep you informed and ahead in the world of health and medicine.

Drug Approvals

AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder

AstraZeneca's Alexion unit has reported divergent outcomes from its...

​Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III

Zydus Lifesciences Limited, in collaboration with the Indian Council of...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand,...

DCGI Approves Qdenga, Marking India’s First Dengue Vaccine

 Takeda Biopharmaceuticals India has received market authorisation from the...

NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib

Alembic Pharmaceuticals Limited announced that its development partner, NATCO...

Pharma Edupoint

CISCE Makes Health and Physical Education Compulsory for Classes 9 to 12 Under NEP 2020

The Council for the Indian School Certificate Examinations (CISCE)...

NCAHP Launches Competency-Based DMLT Curriculum to Update India’s Allied Healthcare Education

The National Commission for Allied and Healthcare Professions (NCAHP),...

Sports Injury Centre and SAI Sign Landmark MoU for Athlete Care

In a major boost to the nation’s sports ecosystem,...

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Choosing the right pharmacy college is one of the...

New Hope for Neuro care: Lupin Opens “Atharv” An Advanced Ability Center in Delhi

Lupin has inaugurated Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center...

Career & Exams

West Bengal to Set up three New Medical college with 300 total MBBS set

The Government of West Bengal has officially initiated the...

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Choosing the right pharmacy college is one of the...

FDA Approves Datroway for Metastatic Triple-Negative Breast Cancer

AstraZeneca and Daiichi Sankyo  announced that the US Food and Drug...

West Bengal Pharmacy Council Announces Online Registration Renewal from August 1, 2026

The West Bengal Pharmacy Council has announced the introduction of an...

UGC-NET 2026 Expansion: Statistics Entry Set to Power Healthcare Analytics, Epidemiology & Medical Research Careers

In a significant academic reform with far-reaching implications for...

AI in Healthcare

Event Now

Global Health

Career & Exam

Latest Articles

NITI Aayog Unveils Strategic Roadmap to Position Ayurveda as a Global Healthcare Force

 NITI Aayog has unveiled a new policy blueprint aimed at elevating Ayurveda's standing on the world stage, developed jointly with PricewaterhouseCoopers (PwC) through the Health Division's...

FSSAI Uncovers Large-Scale Label Tampering Racket at Delhi Food Unit

Acting on a tip-off, the Northern Regional Office of the Food Safety and Standards Authority of India raided a food storage unit run by...

Adani Group to Build ₹2,500 Crore ‘Adani Arogya Mandir’ Health City in Kolkata in Collaboration with Mayo Clinic

The Adani Group has received government approval to establish a state-of-the-art health city, named Adani Arogya Mandir, in New Town, Kolkata. Representing a monumental investment of...

Aster DM Healthcare India and Quality Care India Limited joins force to Create ‘Aster DM Quality Care Ltd.’

Aster DM Healthcare India and Quality Care India Limited have officially combined forces to establish Aster DM Quality Care Ltd., instantly creating one of...

Novartis Receives European Commission Approval for Itvisma®️ for older patient with spinal muscular atrophy

Novartis announced that the European Commission has approved Itvisma® (onasemnogene abeparvovec) for the treatment of 5q spinal muscular atrophy (SMA) with a bi-allelic mutation...

Yashoda hospitals, Hyderabad: where innovation meets compassionate care

For nearly 30 years, Yashoda hospitals has been more than a name in Hyderabad healthcare landscape- it has been a promise. With four thriving...

Subscribe